Paul F. Reid
Geen lopende functies
Profiel
Paul F.
Reid was the founder of ReceptoPharm, Inc. founded in 2001, where he held the title of Chief Executive Officer from 2009 to 2011.
He was also the Chief Executive Officer of Nutra Pharma Corp.
from 2008 to 2010 and held the title of Head-Scientific Affairs at Biotherapeutics, Inc. in 1993.
Dr. Reid obtained a doctorate degree from Imperial College London and an undergraduate degree from Trinity College Dublin in 1987.
Eerdere bekende functies van Paul F. Reid
Bedrijven | Functie | Einde |
---|---|---|
NUTRA PHARMA CORP. | President | 18-11-2009 |
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Corporate Officer/Principal | 01-01-1993 |
ReceptoPharm, Inc.
ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology ReceptoPharm, Inc. develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. It provides benefits for patients with such diseases as acquired immunodeficiency syndrome, multiple sclerosis, myasthenia gravis, and other viral disorders. The company was founded on June 4, 2001 and is headquartered in Plantation, FL. | Algemeen Directeur | - |
Opleiding van Paul F. Reid
Trinity College Dublin | Undergraduate Degree |
Imperial College London | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
NUTRA PHARMA CORP. | Retail Trade |
Bedrijven in privébezit | 2 |
---|---|
ReceptoPharm, Inc.
ReceptoPharm, Inc. Pharmaceuticals: MajorHealth Technology ReceptoPharm, Inc. develops proprietary therapeutic protein products for the prevention and treatment of viral and neurological diseases. It provides benefits for patients with such diseases as acquired immunodeficiency syndrome, multiple sclerosis, myasthenia gravis, and other viral disorders. The company was founded on June 4, 2001 and is headquartered in Plantation, FL. | Health Technology |
Biotherapeutics, Inc.
Biotherapeutics, Inc. BiotechnologyHealth Technology Biotherapeutics, Inc. operates as a pre-clinical stage company which develops small-molecule drugs to treat inflammation and type 2 diabetes. Its scientific foundation is anchored on informatics and computer modeling-enabled drug development with significant animal pharmacology validation. The company was founded by Josep Bassaganya-Riera in 2008 and is headquartered in Blacksburg, VA. | Health Technology |